DCGI grants approval to vaccines of Serum Institute of India, Bharat Biotech

Video Credit: ANI
Published on January 3, 2021 - Duration: 02:10s

DCGI grants approval to vaccines of Serum Institute of India, Bharat Biotech

Drugs Controller General of India VG Somani on January 03 informed that COVID-19 vaccines of Serum Institute of India and Bharat Biotech have been granted permission for restricted use in emergency situation.


You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions

Bharat Biotech

Indian multinational biotechnology company and vaccine manufacturer

Related news from verified sources

The COVID-19 vaccines of the Serum Institute of India and Bharat Biotech have been granted permission for restricted use in an emergency situation.
on January 3, 2021 • DNA

As the Covid-19 vaccine completes its journey from laboratory to hospital, its pricing is being questioned. Public health activists and industry experts to whom...
on January 14, 2021 • IndiaTimes

DGCI on Sunday (January 3) formally approved Serum Institute's Covishield and Bharat Biotech's Covaxin for use in India.ย 
on January 3, 2021 • Zee News

Related videos from verified sources

Covid update: SII seeks Novavax trial approval; virus may affect sperm quality 03:20
Video credit: HT Digital Content - Published on January 29, 2021 

Watch: India sends doses of SIIโ€™s Covishield vaccine to Bahrain, Sri Lanka 01:29
Video credit: HT Digital Content - Published on January 28, 2021 

SII's vaccines reach Mumbai airport for shipping to Bahrain, Colombo 01:41
Video credit: ANI - Published on January 28, 2021 

You might like